The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia Registry
Open accessAbstract
Patients with secondary acute myeloid leukemia (AML) often escape inclusion in clinical trials and thus, population‐based studies are crucial for its accurate characterization. In this first large population‐based study on secondary AML, we studied AML with an antecedent hematological disease (AHD‐AML) or therapy‐related AML (t‐AML) in the population‐based Swedish Acute Leukemia Registry. The study included 3,363 adult patients of which 2,474 (73.6%) had de novo AML, 630 (18.7%) AHD‐AML, and 259 (7.7%) t‐AML. Secondary AML differed significantly compared to de novo AML with respect to age, gender, and cytogenetic risk. Complete remission (CR) rates were significantly lower but early death rates similar in secondary AML. In a multivariable analysis, AHD‐AML (HR 1.51; 95% CI 1.26–1.79) and t‐AML (1.72; 1.38–2.15) were independent risk factors for poor survival. The negative impact of AHD‐AML and t‐AML on survival was highly age dependent with a considerable impact in younger patients, but without independent prognostic value in the elderly. Although patients with secondary leukemia did poorly with intensive treatment, early death rates and survival were significantly worse with palliative treatment. We conclude that secondary AML in a population‐based setting has a striking impact on survival in younger AML patients, whereas it lacks prognostic value among the elderly patients. Am. J. Hematol. 90:208–214, 2015. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Sterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., & Carpenter, J. R. (2009) · BMJ · doi:10.1136/bmj.b2393 · Cited by 7,299
Grimwade, D., Hills, R. K., Moorman, A. V., Walker, H., Chatters, S., Goldstone, A. H., Wheatley, K., Harrison, C. J., Burnett, A. K., & on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) · Blood · doi:10.1182/blood-2009-11-254441 · Cited by 1,938
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,633
Juliusson, G., Antunovic, P., Derolf, Å., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A., & Höglund, M. (2009) · Blood · doi:10.1182/blood-2008-07-172007 · Cited by 987
Self-citationSmith, S. M., Le Beau, M. M., Huo, D., Karrison, T., Sobecks, R. M., Anastasi, J., Vardiman, J. W., Rowley, J. D., & Larson, R. A. (2003) · Blood · doi:10.1182/blood-2002-11-3343 · Cited by 682
Kayser, S., Döhner, K., Krauter, J., Köhne, C.-H., Horst, H. A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., Kündgen, A., Götze, K., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301713 · Cited by 487
Schoch, C., Schnittger, S., Klaus, M., Kern, W., Hiddemann, W., & Haferlach, T. (2003) · Blood · doi:10.1182/blood-2003-02-0434 · Cited by 352
Lehmann, S., Ravn, A., Carlsson, L., Antunovic, P., Deneberg, S., Möllgård, L., Rangert Derolf, Å., Stockelberg, D., Tidefelt, U., Wahlin, A., et al. (2011) · Leukemia · doi:10.1038/leu.2011.78 · Cited by 343
Self-citationLeukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
Levine, E. G., & Bloomfield, C. D. (1992) · PubMed · Cited by 301
The incidence of secondary leukemias.
Leone, G. G. M., Mele, L., b, A. P., et al. (1999) · PubMed · Cited by 292
Schoch, C., Kern, W., Schnittger, S., Hiddemann, W., & Haferlach, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403187 · Cited by 284
Wheatley, K., Brookes, C. L., Howman, A. J., Goldstone, A. H., Milligan, D. W., Prentice, A. G., Moorman, A. V., Burnett, A. K., & on behalf of the United Kingdom National Cancer Research Institute Haematological Oncology Clinical Studies Group and Acute Myeloid Leukaemia Subgroup (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07663.x · Cited by 236
Independent prognostic factors for AML outcome
Grimwade, D., & Hills, R. K. (2009) · Hematology · doi:10.1182/asheducation-2009.1.385 · Cited by 180
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson, R. A. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.10.006 · Cited by 90
Pagano, L., Pulsoni, A., Tosti, M. E., Avvisati, G., Mele, L., Mele, A., Martino, B., Visani, G., Cerri, R., Bona, E. D., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02527.x · Cited by 65
Lazarević, V., Hörstedt, A.-S., Johansson, B., Antunović, P., Billström, R., Derolf, Å. R., Hulegårdh, E., Lehmann, S., Möllgård, L., Nilsson, C. C., et al. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.10 · Cited by 62
Self-citationReasons for treating secondary AML as de novo AML
Østgård, L. S. G., Kjeldsen, E., Holm, M. S., Brown, P. D. N., Pedersen, B. B., Bendix, K., Johansen, P., Kristensen, J. S., & Nørgaard, J. M. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01464.x · Cited by 57
Stölzel, F., Pfirrmann, M., Aulitzky, W. E., Kaufmann, M., Bodenstein, H., Bornhäuser, M., Röllig, C., Krämer, M., Mohr, B., Oelschlägel, U., et al. (2010) · Leukemia · doi:10.1038/leu.2010.279 · Cited by 33
Preiss, B., Bergmann, O. J., Friis, L. S., Sørensen, A. G., Frederiksen, M., Gadeberg, O., Mourits‐Andersen, T., Oestergaard, B., & Kerndrup, G. B. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.06.013 · Cited by 31
Cited by
‘Acute myeloid leukemia: a comprehensive review and 2016 update’
De Kouchkovsky, I., & Abdul-Hay, M. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.50 · Cited by 1,317
Granfeldt Østgård, L. S., Medeiros, B. C., Sengeløv, H., Nørgaard, M., Andersen, M. K., Dufva, I. H., Friis, L. S., Kjeldsen, E., Marcher, C. W., Preiss, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0890 · Cited by 451
Advances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 440
Therapy-related myeloid neoplasms: when genetics and environment collide
McNerney, M. E., Godley, L. A., & Le Beau, M. M. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.60 · Cited by 419
Krauss, A. C., Gao, X., Li, L., Manning, M. L., Patel, P., Fu, W., Janoria, K. G., Gieser, G., Bateman, D. A., Przepiorka, D., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2990 · Cited by 332
Metadata
- Authors
- Hulegårdh, E., Nilsson, C., Lazarevic, V., Garelius, H., Antunovic, P., Rangert Derolf, Å., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., Höglund, M., Juliusson, G., Stockelberg, D., & Lehmann, S.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2015-01-16
- Volume
- 90
- Issue
- 3
- Pages
- 208-214
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2123331484
- Cited by
- 269
- References
- 21
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.